Saemmul O Il Control Cushion 02 Natural Beige Breastfeeding
Most health expert recommend six month of exclusive breastfeeding but statics suggest that numbers are not good, almost 95% mothers start breastfeeding but this number drops to 40% in first three month and further it drops to 15% till fifth month. Sometime its due to need of medication usage. Because of these statics its important to provide good information on safety of drugs in breastfeeding so that it can be improved when possible. In this FAQ sheet we will discuss about exposure to Saemmul O Il Control Cushion 02 Natural Beige while breastfeeding. We will also discuss about common side effects and warnings associated with Saemmul O Il Control Cushion 02 Natural Beige.

What is usage and purpose of Saemmul O Il Control Cushion 02 Natural Beige ?

Sunscreen

I am currently breastfeeding and I want to know if using Saemmul O Il Control Cushion 02 Natural Beige is safe for my kid? Does it have any effect on milk production?

Saemmul O Il Control Cushion 02 Natural Beige high risk while breastfeeding
There are total 4 active ingredients in Saemmul O Il Control Cushion 02 Natural Beige which makes it a complicated task to assess the effect of Saemmul O Il Control Cushion 02 Natural Beige on breastfeeding. Here on drlact after analyzing all 4 ingredients we have reached on conclusion that Saemmul O Il Control Cushion 02 Natural Beige is unsafe in breastfeeding. Below is our summarized analysis of Titanium dioxide, Octinoxate, Zinc cation, Octisalate.

Saemmul O Il Control Cushion 02 Natural Beige Breastfeeding Analsys


Zinc cation while Breastfeeding

Safe

CAS Number: 1314-13-2

It is used topically as an astringent and skin protector, very often together with small amounts of Ferric Oxide to form Calamine (see specific info). It is a product compatible with breastfeeding according to WHO Essential Medicine’s List - 2002.It is also used in dental hygiene products and cosmetics. Widely used for skin protection of the diaper area in infants. Because of the small dose used and poor absorption into plasma of most topical dermatological preparations, excretion into breastmilk in significant amount appears to be unlikely. Do not apply on the breast to prevent infant ingestion; otherwise, wash it off thoroughly with water before the next breast feed.


Saemmul O Il Control Cushion 02 Natural Beige Breastfeeding Analsys - 2


Titanium dioxide and Breastfeeding

Low Risk

Not much study has been done on effects of topical usage of Titanium Dioxide during breast feeding but as there is no finding of Titanium Dioxide passing in breast milk its unlikely to cause any health issue for infant.

Some animal studies suggest that maternal exposure to titanium dioxide nanoparticles during pregnancy and lactation alters offspring hippocampal mRNA BAX and Bcl-2 levels, induces apoptosis and decreases neurogenesis. But dosage was significantly higher than daily possible exposure to humans.

Note: Study and data for tropical use only. Inhalation concerns in powder or spray products.

Warning: Tropical usage in breast area shall be avoided to prevent the Titanium Dioxide passing orally in Infants. Titanium dioxide is possibly carcinogenic to humans. Titanium dioxide can be drastically more harmful if used as powder or spray as risk of inhalation can increase significantly.

Octinoxate and Breastfeeding

Unsafe

Octinoxate (Octylmethoxycinnamate) has been detected in human urine, blood and breast milk and is known for moderate risk of skin allergy. Some studies suggest that Octinoxate has estrogen like effects however less than 1% skin penetration has been found in human laboratory studies. As not much study has been done on effects of Octinoxate during breast feeding its recommended to use safe alternatives.

Octyl Methoxycinnamate (OMC) is a frequently used UV-filter in sunscreens and other cosmetics. Octinoxate can be systemically absorbed after skin application, being found in the deeper layers of the stratum corneum as well as urine, plasma, and breast milk. The mean maximum plasma concentration detected after application of 2mg/cm2 sunscreen was 7ng/mL in women and 16ng/mL in men. FDA study found blood levels 13 times above cutoff for systemic exposure.

Several studies indicated that OMC acts as an endocrine disruptor due to the ability to interfere with endocrine system at different levels. In humans OMC exposure has minor, but statistically significant effects on the levels of testosterone and estradiol. Moreover, some studies suggested that OMC can interact with the hypothalamo-pituitary-thyroid (HPT) axis.

Moreover, a study of offspring of dams treated with OMC (500Ė1000 mg/kg/day) showed sex-dependent behavioral changes, namely decreased motor activity in females, but not in males, and improved spatial learning in males, suggesting that OMC can affect neuronal development, however the doses used in these experiments were extremely high, not relevant to possible human exposure.

Note: Study and data for tropical use only

Warning: High dosage shall be avoided as reproductive system, thyroid and behavioral alterations in animal studies has been found, Tropical usage in breast area shall be avoided to prevent the OCTINOXATE passing orally in Infants.

Octisalate and Breastfeeding

Low Risk

Octyl salicylate is an oil soluble chemical sunscreen agent that absorbs UVB radiation. It does not protect against UVA. Octyl salicylate is used to augment the UVB protection in a sunscreen. Salicylates are weak UVB absorbers and they are generally used in combination with other UV filters

Octisalate rarely causes allergies in tropical usage. Not much study has been done on effects of topical usage of Octisalate during breast feeding however it is known to penetrate the skin hence itís better to use other alternatives.

FDA study found blood levels 10 times above cutoff for systemic exposure, skin penetration in lab studies has been observed

Note: Study and data for tropical use only

Warning: Tropical usage in breast area shall be avoided to prevent the Octisalate passing orally in Infants.


What should I do if already breastfed my kid after using Saemmul O Il Control Cushion 02 Natural Beige?

We have already established that Saemmul O Il Control Cushion 02 Natural Beige is unsafe in breastfeeding and breastfeeding while using Saemmul O Il Control Cushion 02 Natural Beige is not a good idea however if have already used and then breastfed the baby then you shall monitor the behavior and health of baby closely and inform your doctor as soon as possible. In case of emergency please call 911.


My health care provider has asked me to use Saemmul O Il Control Cushion 02 Natural Beige, what to do?

If your doctor knows that you are breastfeeding mother and still prescribes Saemmul O Il Control Cushion 02 Natural Beige then there must be good reason for that as Saemmul O Il Control Cushion 02 Natural Beige is considered unsafe, It usually happens when doctor finds that overall advantage of taking outweighs the overall risk.


If I am using Saemmul O Il Control Cushion 02 Natural Beige, will my baby need extra monitoring?

Yes, Extra monitoring is required if mother is using Saemmul O Il Control Cushion 02 Natural Beige and breastfeeding as it is considered unsafe for baby.


Who can I talk to if I have questions about usage of Saemmul O Il Control Cushion 02 Natural Beige in breastfeeding?

US
National Womens Health and Breastfeeding Helpline: 800-994-9662 (TDD 888-220-5446) 9 a.m. and 6 p.m. ET, Monday through Friday

UK
National Breastfeeding Helpline: 0300-100-0212 9.30am to 9.30pm, daily
Association of Breastfeeding Mothers: 0300-330-5453
La Leche League: 0345-120-2918
The Breastfeeding Network supporter line in Bengali and Sylheti: 0300-456-2421
National Childbirth Trust (NCT): 0300-330-0700

Australia
National Breastfeeding Helpline: 1800-686-268 24 hours a day, 7 days a week

Canada
Telehealth Ontario for breastfeeding: 1-866-797-0000 24 hours a day, 7 days a week